TRLV Trulieve Cannabis
Trulieve Cannabis earnings company data as of 4:47 AM ET 10/24
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 5 Nov | EPS | 0.09 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by TRLV's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- None no sales outside a trading plan
- $14.7M sold by 1 insider under 10b5-1 plans
-
Kim A. Rivers CEOPlanned sale$1.2M 136,811 shares at $8.76 8.5% of stakeTraded Jun 26 Filed Jun 26
-
Kim A. Rivers CEOPlanned sale$8.9M 1,080,000 shares at $8.27 40% of stakeTraded Jun 23–25 Filed Jun 25
-
Kim A. Rivers CEOPlanned sale$4.5M 482,196 shares at $9.39 15% of stakeTraded Jun 17–22 Filed Jun 22
Also filed in the last 12 months, not counted as buying or selling: 16 stock grants, 7 share withholdings for taxes, and 1 conversion.
SEC filings
Recent issuer filings from EDGAR, 22 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 1.01,3.02,3.03,5.03,9.01 | Filing Doc | |
| 8-K | 2.01,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 5.07,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| 8-K | 5.02,9.01 | Filing Doc | |
| 8-K | 5.07,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 1.01,2.01,9.01 | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| 8-K | 5.02 | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 10-K | Filing Doc | ||
| 8-K | 5.02 | Filing Doc | |
| 8-K | 1.01,2.03,8.01,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.